
Fate Therapeutics
IPOPublic · La Jolla, United States · Founded 2007 · $30.0M raised
- Headquarters
- La Jolla, California
- Employees
- 51–200
- Founded
- 2007
- Business Model
- B2B
- Website
- fatetherapeutics.com
- Total Funding
- $30.0M
- Last Round
- $30.0M Series BNov 2009
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 1 investor for this company. The full record is or through the API.
About
Clinical-stage biopharmaceutical company developing iPSC-derived cellular immunotherapies for autoimmune diseases and cancer.
Summary
Fate Therapeutics is a Biotech company based in La Jolla, United States, founded in 2007. It has raised $30.0M in total across 1 round, most recently a $30.0M Series B round in Nov 2009. Investors include OVP Venture Partners.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Mar 2024
Sign up to see all 4 events
Funding: Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/fate-therapeutics"><img src="https://indexed.vc/api/badge/company/fate-therapeutics" alt="Fate Therapeutics on Indexed.vc" width="260" height="76" /></a>

